NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML)
Clinical trials for NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML) explained in plain language.
Never miss a new study
Get alerted when new NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML) trials appear
Sign up with your email to follow new studies for NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for older leukemia patients: drug combo aims for higher remission
Disease control Recruiting nowThis study tests a new combination of drugs (venetoclax, azacitidine, chidamide, and others) against the standard chemotherapy for adults aged 60-75 with newly diagnosed acute myeloid leukemia (AML). The goal is to see if the new combo leads to more remissions and fewer side effe…
Matched conditions: NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML)
Phase: PHASE2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug cocktail aims to beat leukemia in patients too frail for standard chemo
Disease control Recruiting nowThis phase II trial is testing a combination of two drug regimens—VA (venetoclax and azacitidine) and low-dose CHA (cladribine, homoharringtonine, and cytarabine)—given in alternating cycles to newly diagnosed acute myeloid leukemia (AML) patients aged 60 or older who cannot tole…
Matched conditions: NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML)
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC